People · Operator
Named in public records as an officer, director or promoter · active 2011–2011 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| iTherx Pharma, Inc. | — | Pharmaceuticals | Seed | $3.2M | $120.7M | 2011 |
Eve H. Slater at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Eve H. Slater on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John H. Friedman | 1 | 3 |
| Steven B. Gerber, M.D. | 1 | 2 |
| Jeffrey F. McKelvy, Ph.D. | 1 | 2 |
| Frank F. Litvack, M.D. | 1 | 2 |
| Amanda H. Iles | 1 | 1 |
| Franklin H. Berger | 1 | 1 |
| Flossie F. Wong-Staal, Ph.D. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.